InvestorsHub Logo
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

Re: biomaven0 post# 16234

Friday, 02/03/2012 3:02:16 PM

Friday, February 03, 2012 3:02:16 PM

Post# of 80490
So, in theory, pts who show low frequency mutations on gleevec could be switched to ponatinib after only three months? I don't think that's built into any ones model yet, lol.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.